Polyclonal Rabbit anti‑Human Fragilis / IFITM3 Antibody (10‑90 aa, N‑terminal, IF, WB) LS‑C384055
Polyclonal Rabbit anti‑Human Fragilis / IFITM3 Antibody (10‑90 aa, N‑terminal, IF, WB) LS‑C384055
Antibody:
Fragilis / IFITM3 Rabbit anti-Human Polyclonal (10-90 aa, N-terminal) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
Fragilis / IFITM3 Rabbit anti-Human Polyclonal (10-90 aa, N-terminal) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
IFITM3 antibody LS-C384055 is an unconjugated rabbit polyclonal antibody to human IFITM3 (Fragilis) (10-90 aa, N-terminal). Validated for ELISA, IF and WB.
Target
Human Fragilis / IFITM3
Synonyms
IFITM3 | 1-8U | Dispanin subfamily A member 2b | DSPA2b | Fragilis | IP15
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human IFITM3
Epitope
10-90 aa, N-terminal
Specificity
IFITM3 Polyclonal Antibody detects endogenous levels of IFITM3 protein.
Applications
- Immunofluorescence (1:200 - 1:1000)
- Western blot (1:500 - 1:2000)
- ELISA (1:40000)
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, ICC, Western blot
Species:
Human
Applications:
ICC, Immunofluorescence, Western blot
Species:
Human
Applications:
Immunofluorescence, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Mouse, Rat
Applications:
Western blot
Species:
Human
Applications:
Western blot
Species:
Human
Applications:
Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/22/2024